Development of oral and parenteral dosage forms;Entwicklung oraler und parenteraler Arzneiformen

Pharmazie in Unserer Zeit

Volumn 34, Issue 4, 2005, Pages 296-303

  Schubert, Rolf ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; CYTOSTATIC AGENT; DACLIZUMAB; DOUGLAN; EFALIZUMAB; ETANERCEPT; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PIMECROLIMUS; RAPAMYCIN; SDZ RAD RAD001; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

DRUG DEVELOPMENT; DRUG DOSAGE FORM; GERMANY; HUMAN; IMMUNOTHERAPY; MICROEMULSION; REVIEW; SUSPENSION; TABLET FORMULATION;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS;

EID: 22244480077     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200500129     Document Type: Review

References (22)

1. European Medicines Agency (EMEA): Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98 (1998).
2. Lipinski, C.A., Lomardo, F., Dominy, B.W., Feeney, P.J.: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 23 (1997), 3-25.
3. Löbenberg, R., Amidon, G.L.: Modern bioavailability, bioequivanece and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50 (2000), 3-12.
4. Strickley, R.G.: Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21 (2004), 201-270.
5. Rabinow, B.E.: Nanosuspensions in drugs delivery. Nature Rev. Drug Discovery 3 (2004), 785-796.
6. Conner, S.D., Schmidt, S.L.: Regulated portals of entry into the cell. Nature 422 (2003), 37-44.
7. Huth, U., Wieschollek, A., Garini, Y., Schubert, R., Peschka-Süss, R.: Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes. Cytometry Part A 57A(2004), 10-21.
8. Shakweh, M., Ponchel, G., Fattal, E.: Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin. Drug Del. 1 (2004), 141-163.
9. Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., Yamamoto, A.: Modulation of intestinal P-glycoprotein function by cremophor-EL and other surfactants by an in vitro diffusion chamber method using isolated rat intestinal membranes. J. Pharm. Sci. 93 (2004), 877-885.
10. Hoar, T.P., Schulman, J.H.: Transparent water-in-oil dispersions: the oleopathic hydro-micelle. Nature 152 (1943), 102-103.
11. Schulman, H.J., Stoeckenius, W., Prince, L.M.: Mechanism of formation and structure of microemulsions by electron microscopy. J. Phys. Chem. 63 (1959), 1677-1680.
12. Lawrence, M.J., Rees, G.D.: Microemulsion-based media as novel drug delivery systems. Adv. Drug. Del. Rev. 45 (2000), 89-12.
13. Ritschel, W.A.: Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral. Clin. Transplantation 10 (1996), 364-373.
14. Kees, F., Mair, G., Dittmar, M., Bucher, M.: Cicloral versus Neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of Cicloral. Transplantation Proc. 36 (2004), 3234-3238.
15. Chiou, W.L., Riegelman, S.: Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (1971), 1281-1302.
16. Honbo, T., Kobayashi, M., Hane, K., Hata, T., Ueda, Y.: The oral dosage form of FK-505. Transpl. Proc. 19, Suppl. 6 (1987), 17-22.
17. Zimmer, A.: Galenische Formulierungen rekombinanter Wirkstoffe. Phar. Unserer Zeit 32 (2003), 384-398.
18. Wang, Y.P., Pearlman, R. (eds.): Stability and characterisation of protein and peptide drugs. Pharmaceutical Biotechnology Vol. 5, Penum Press (1993).
19. Wang, Y.P., Pearlman, R. (eds.): Stability and characterisation of protein and peptide drugs. Case Histories. Pharmaceutical Biotechnology Vol. 9, Penum Press (1993).
20. McNally, E.J. (ed.): Protein formulation and delivery. Marcel Dekker (2000).
21. Ahern, T.J., Manning, M.C. (eds.): Stability of protein pharmaceuticals, Part A and B. Plenum Press (1992).
22. Baskakov, I., Bolen, D.W.: Forcing thermodynamically unfolded proteins to fold. J. Biol. Chem. 273 (1998), 4831-4834.